These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 38466642)
21. Identification of Arp2/3 Complex Subunits as Prognostic Biomarkers for Hepatocellular Carcinoma. Huang S; Li D; Zhuang L; Sun L; Wu J Front Mol Biosci; 2021; 8():690151. PubMed ID: 34307456 [TBL] [Abstract][Full Text] [Related]
22. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma. Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688 [TBL] [Abstract][Full Text] [Related]
23. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples. Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347 [TBL] [Abstract][Full Text] [Related]
24. Identification of immune-related target and prognostic biomarkers in PBMC of hepatocellular carcinoma. Hu R; Zhang W; Han Z; Ma M; Huang Q; Lv M; Ma W; Sun X; Feng W; Li J; Zhong X; Sun J; Yao W; Zhou X BMC Gastroenterol; 2023 Jul; 23(1):234. PubMed ID: 37438735 [TBL] [Abstract][Full Text] [Related]
25. CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein. Huang M; Xiong H; Luo D; Xu B; Liu H Exp Cell Res; 2020 Mar; 388(2):111876. PubMed ID: 31991125 [TBL] [Abstract][Full Text] [Related]
26. Prefoldin and prefoldin-like complex subunits as predictive biomarkers for hepatocellular carcinoma immunotherapy. Zhao H; Chen C; Yang C; Mo S; Zhao H; Tian Y Pathol Res Pract; 2022 Apr; 232():153808. PubMed ID: 35217267 [TBL] [Abstract][Full Text] [Related]
27. CSN1 facilitates proliferation and migration of hepatocellular carcinoma cells by upregulating cyclin A2 expression. Fu H; Zhang Y; Chen Y; Chen J; Chen P Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200803 [TBL] [Abstract][Full Text] [Related]
28. Cell division cycle-associated 8 is a prognostic biomarker related to immune invasion in hepatocellular carcinoma. Wu H; Liu S; Wu D; Zhou H; Sui G; Wu G Cancer Med; 2023 Apr; 12(8):10138-10155. PubMed ID: 36855818 [TBL] [Abstract][Full Text] [Related]
29. The COP9 signalosome inhibits Cullin-RING E3 ubiquitin ligases independently of its deneddylase activity. Suisse A; Békés M; Huang TT; Treisman JE Fly (Austin); 2018; 12(2):118-126. PubMed ID: 29355077 [TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis and validation of SNX7 as a novel biomarker for the diagnosis, prognosis, and prediction of chemotherapy and immunotherapy response in hepatocellular carcinoma. Chen J; Gao G; Zhang Y; Dai P; Huang Y BMC Cancer; 2023 Sep; 23(1):899. PubMed ID: 37743471 [TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of the correlation of the pan-cancer gene HAUS5 with prognosis and immune infiltration in liver cancer. Zhang W; Yang C; Hu Y; Yi K; Xiao W; Xu X; Chen Z Sci Rep; 2023 Feb; 13(1):2409. PubMed ID: 36765148 [TBL] [Abstract][Full Text] [Related]
32. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model. Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737 [TBL] [Abstract][Full Text] [Related]
33. High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma. Li S; Huang J; Yang F; Zeng H; Tong Y; Li K Sci Rep; 2021 May; 11(1):11078. PubMed ID: 34040099 [TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma. Liu C; Wu S; Lai L; Liu J; Guo Z; Ye Z; Chen X BMC Bioinformatics; 2023 Jan; 24(1):4. PubMed ID: 36597032 [TBL] [Abstract][Full Text] [Related]
35. G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma. Wang H; Yu L; Cui Y; Huang J Dis Markers; 2022; 2022():1313359. PubMed ID: 35686033 [TBL] [Abstract][Full Text] [Related]
36. Elevated expression of TNFRSF4 impacts immune cell infiltration and gene mutation in hepatocellular carcinoma. Wang D; Hu H; Ding H; Zhao H; Tian F; Chi Q Cancer Biomark; 2023; 36(2):147-159. PubMed ID: 36591653 [TBL] [Abstract][Full Text] [Related]
37. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma. Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731 [TBL] [Abstract][Full Text] [Related]
38. N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma. Cai J; Zhou M; Xu J World J Surg Oncol; 2021 Aug; 19(1):241. PubMed ID: 34389000 [TBL] [Abstract][Full Text] [Related]
39. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker. Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352 [TBL] [Abstract][Full Text] [Related]
40. Systematic analysis of the role of LDHs subtype in pan-cancer demonstrates the importance of LDHD in the prognosis of hepatocellular carcinoma patients. Wang S; Wu X; Wu X; Cheng J; Chen Q; Qi Z BMC Cancer; 2024 Jan; 24(1):156. PubMed ID: 38291366 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]